|
Volumn 31, Issue 7, 2008, Pages
|
Mind the gap when managing ketoacidosis in type 1 diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 HYDROXYBUTYRIC ACID;
BENZODIAZEPINE DERIVATIVE;
BICARBONATE;
CANNABIS;
DIAMORPHINE;
GLUCOSE;
INSULIN;
KETAMINE;
KETONE;
DESIGNER DRUG;
ARTERIAL PH;
DRUG DETOXIFICATION;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN INFUSION;
KETOACIDOSIS;
LETTER;
PATIENT COMPLIANCE;
PATIENT COUNSELING;
SUBSTANCE ABUSE;
ADDICTION;
ADULT;
BLOOD;
CHEMICALLY INDUCED DISORDER;
DIABETIC KETOACIDOSIS;
GLUCOSE BLOOD LEVEL;
HYPERGLYCEMIA;
METABOLISM;
MIDDLE AGED;
RETROSPECTIVE STUDY;
3-HYDROXYBUTYRIC ACID;
ADULT;
BLOOD GLUCOSE;
DESIGNER DRUGS;
DIABETES MELLITUS, TYPE 1;
DIABETIC KETOACIDOSIS;
HUMANS;
HYPERGLYCEMIA;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
SUBSTANCE-RELATED DISORDERS;
|
EID: 49649126877
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc08-0690 Document Type: Letter |
Times cited : (16)
|
References (5)
|